The First Drug That Fixes Schizophrenia’s Core Signal | Cobenfy Explained

For 70 years, every schizophrenia drug worked the same way—blocking dopamine receptors everywhere. It stopped hallucinations, but caused devastating side effects: uncontrollable movements, massive weight gain, and emotional numbness. Then Cobenfy changed everything. In this video, I break down the actual neuroscience: why dopamine isn't just "too high" in schizophrenia, how the mesolimbic and prefrontal pathways are dysregulated in opposite directions, and why blocking D2 receptors everywhere was never going to work. Then I explain how Cobenfy targets M1 and M4 muscarinic receptors to restore natural dopamine balance across different brain circuits—without the brutal side effects that plagued patients for decades. ⏱️ TIMESTAMPS: 0:00 - What we got wrong about schizophrenia 0:30 - The dopamine pathway problem 2:00 - How Cobenfy actually works 3:00 - Why this breakthrough matters I'm Dr. G, a family medicine physician breaking down how medications actually work at the molecular level. 🔔 Subscribe for more drug mechanism breakdowns 📱 Follow on X: @DrG_Medicine --- TOPICS COVERED: Schizophrenia treatment | Antipsychotic medications | Dopamine pathways | Mesolimbic pathway | Prefrontal cortex | Nigrostriatal pathway | Basal ganglia | D2 receptor blockade | M1 M4 muscarinic receptors | Cobenfy xanomeline trospium | Tardive dyskinesia | Extrapyramidal symptoms | Neuroscience explained | Pharmacology | Mental health | Psychiatry | Medical education | Drug mechanisms | How medications work | Family medicine Related searches: schizophrenia drugs side effects, new schizophrenia medication 2024, how antipsychotics work, dopamine and schizophrenia, Cobenfy mechanism of action, why do antipsychotics cause weight gain, tardive dyskinesia explained, muscarinic receptors schizophrenia